Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia

Insulin detemir is commonly used in obese patients with diabetes mellitus as it is considered hepatoselective and causes less weight gain. We describe a relative lack of effectiveness of detemir in patients with significant NAFLD and hypertriglyceridemia, compared to isophane insulin. This may affec...

Descripción completa

Detalles Bibliográficos
Autores principales: Whyte, Martin, Quaglia, Alberto, Hopkins, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706392/
https://www.ncbi.nlm.nih.gov/pubmed/26783443
http://dx.doi.org/10.1002/ccr3.458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706392/
https://www.ncbi.nlm.nih.gov/pubmed/26783443
http://dx.doi.org/10.1002/ccr3.458

Ejemplares similares